Early Diagnostic Telehealth for Autism

This trial aims to test a new telehealth approach for diagnosing autism in young children. It will evaluate the ease and effectiveness of this method for families and clinicians. The trial seeks families with children enrolled in Georgia's Babies Can't Wait program who have been identified as moderate- or high-risk for autism. Parents and caregivers must be able to complete forms and interviews in English.

As an unphased trial, this study provides families the opportunity to contribute to innovative research that could enhance autism diagnosis methods.

The trial information does not specify whether your child needs to stop taking current medications. It's best to discuss this with the trial coordinators or your child's healthcare provider.

Research has shown that early diagnostic tools for autism, such as the Early Diagnostic Response Model Expanded, can help identify autism in young children. Although researchers are still studying this specific tool, similar methods have demonstrated positive results in diagnosing autism early and improving children's adaptability.

The reviewed studies did not identify any major safety issues with these diagnostic methods. Since this trial is in a "Not Applicable" phase, it focuses on the practicality and ease of use of these methods, rather than testing drug safety. The procedures are non-invasive and mainly involve assessments and questionnaires, which are generally safe.

Researchers are excited about the Early Diagnostic Response Model Expanded for autism because it leverages telehealth to provide early and accessible diagnosis. Unlike traditional in-person assessments, this approach allows children as young as 16 months to be evaluated remotely, making it more convenient for families and potentially reaching those in underserved areas. Additionally, the comprehensive use of standardized measures and parent/caregiver input throughout the process ensures a thorough and personalized assessment. This innovative model could lead to earlier interventions and better outcomes for children with suspected autism.

This trial will evaluate the Early Diagnostic Response Model Expanded, which uses telehealth to diagnose autism spectrum disorder (ASD) in young children. Studies have shown that telehealth can reliably diagnose ASD. One review found that telehealth methods accurately diagnose ASD early by using both live and recorded information. Telehealth improves access and reduces costs, making it easier for families to receive care and allowing for timely assessments. Research shows that caregivers often express high satisfaction with telehealth's mixed approaches for autism evaluations. Overall, telehealth is transforming autism diagnosis by offering effective and accessible options for families.⁴⁶⁷⁸⁹